Inpatient HF Cohort Drive Higher Post-Index Costs*

*All comparisons were statistically significant at P<0.001, with the exception of ER costs in the high risk cohort which was statistically significant at P=0.004†Other outpatient visits may include labs, diagnostics, home health, etc.HF - heart failure; USD - United States dollars.Low Risk: HF (n=5,128); Non-HF (n=5,128)High Risk: HF (n=301); Non-HF (n=301)Please see the poster for demographic data.

Inpatient costs accounted for the largest difference, and were 5.4 and 7.9 times higher in the HF cohort compared to the non-HF cohort among low- and high-risk patients, respectively.